These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18666246)

  • 1. Statins in liver disease: a molehill, an iceberg, or neither?
    Argo CK; Loria P; Caldwell SH; Lonardo A
    Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins in chronic liver diseases: safety and effect].
    Li GM; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):478-80. PubMed ID: 20587326
    [No Abstract]   [Full Text] [Related]  

  • 4. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of statins in patients with chronic hepatitis C.
    Andrus MR; East J
    South Med J; 2010 Oct; 103(10):1018-22; quiz 1023. PubMed ID: 20818300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and nonalcoholic fatty liver disease: a bright future?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1089-93. PubMed ID: 23889731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid-lowering treatment and liver dysfunction].
    Gencer B; Moradpour D; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):507-8, 510-2. PubMed ID: 22471112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The double-edged sword of statin immunomodulation.
    Goldstein MR; Mascitelli L; Pezzetta F
    Int J Cardiol; 2009 Jun; 135(1):128-30. PubMed ID: 18485499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
    Athyros VG; Tziomalos K; Daskalopoulos GN; Karagiannis A; Mikhailidis DP
    Ann Med; 2011 May; 43(3):167-71. PubMed ID: 21476786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of statins in treating liver disease.
    Imprialos KP; Stavropoulos K; Doumas M; Skalkou A; Zografou I; Athyros VG
    Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):331-339. PubMed ID: 29431526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of statin safety by hepatologists.
    Cohen DE; Anania FA; Chalasani N;
    Am J Cardiol; 2006 Apr; 97(8A):77C-81C. PubMed ID: 16581333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug insight: statins and gastrointestinal cancer.
    Bhuket TP; Higgins PD
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):552-62. PubMed ID: 17008925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and prostate cancer prevention: where we are now, and future directions.
    Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
    Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and statins.
    Tziomalos K; Athyros VG; Paschos P; Karagiannis A
    Metabolism; 2015 Oct; 64(10):1215-23. PubMed ID: 26234727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and hepatitis C virus infection: an old therapy with new scope.
    Rzouq F; Alahdab F; Olyaee M
    Am J Med Sci; 2014 Nov; 348(5):426-30. PubMed ID: 24805786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver function tests and statins.
    Zamor PJ; Russo MW
    Curr Opin Cardiol; 2011 Jul; 26(4):338-41. PubMed ID: 21499089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of statins on MHC class I expression.
    Singh P; Kohr D; Kaps M; Blaes F
    Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of statins.
    Brown WV
    Curr Opin Lipidol; 2008 Dec; 19(6):558-62. PubMed ID: 18957877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.